Literature DB >> 15466867

Expression of the vacuolar H+-ATPase 16-kDa subunit results in the Triton X-100-insoluble aggregation of beta1 integrin and reduction of its cell surface expression.

Intaek Lee1, Mhairi A Skinner, Hua-bei Guo, Avinash Sujan, Michael Pierce.   

Abstract

Vacuolar H(+)-ATPase functions as a vacuolar proton pump and is responsible for acidification of intracellular compartments such as the endoplasmic reticulum, Golgi, lysosomes, and endosomes. Previous reports have demonstrated that a 16-kDa subunit (16K) of vacuolar H(+)-ATPase via one of its transmembrane domains, TMD4, strongly associates with beta(1) integrin, affecting beta(1) integrin N-linked glycosylation and inhibiting its function as a matrix adhesion receptor. Because of this dramatic inhibition of beta(1) integrin-mediated HEK-293 cell motility by 16K expression, we investigated the mechanism by which 16 kDa was having this effect. Using HT1080 cells whose alpha(5)beta(1) integrin-mediated adhesion to fibronectin has been extensively studied, the expression of 16 kDa also resulted in reduced cell spreading on fibronectin-coated substrates. A pulse-chase study of beta(1) integrin biosynthesis indicated that 16K expression down-regulated the level of the 110-kDa biosynthetic form of beta(1) integrin (premature form) and, consequently, the level of the 130-kDa form of beta(1) integrin (mature form). Further experiments showed that the normal levels of association between the premature beta(1) integrin form and calnexin were significantly decreased by the expression of either 16 kDa or TMD4. Expression of 16 kDa also resulted in a Triton X-100-insoluble aggregation of an unusual 87-kDa form of beta(1) integrin. Interestingly, both Western blotting and a pulse-chase experiment showed co-immunoprecipitation of calnexin and 16K. These results indicate that 16K expression inhibits beta(1) integrin surface expression and spreading on matrix by a novel mechanism that results in reduced levels of functional beta(1) integrin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15466867     DOI: 10.1074/jbc.M405717200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  CLCA splicing isoform associated with adhesion through β1-integrin and its scaffolding protein: specific expression in undifferentiated epithelial cells.

Authors:  Jun Yamazaki; Kazuhiko Okamura; Kiyoko Uehara; Mitsutoki Hatta
Journal:  J Biol Chem       Date:  2013-01-07       Impact factor: 5.157

2.  Transmembrane BAX inhibitor motif containing (TMBIM) family proteins perturbs a trans-Golgi network enzyme, Gb3 synthase, and reduces Gb3 biosynthesis.

Authors:  Toshiyuki Yamaji; Kiyotaka Nishikawa; Kentaro Hanada
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

3.  [Novel tumor metastasis suppressorgene LASS2/TMSG1 S248A mutant promotes invasion of prostate cancer cells through increasing ATP6V0C expression].

Authors:  K G Zhang; Y H Zhou; Y K Shao; F Mei; J F You; B Y Liu; F Pei
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-04-18

4.  Heme-binding protein HRG-1 is induced by insulin-like growth factor I and associates with the vacuolar H+-ATPase to control endosomal pH and receptor trafficking.

Authors:  Katie M O'Callaghan; Veronica Ayllon; Jean O'Keeffe; Yanru Wang; Orla T Cox; Gary Loughran; Michael Forgac; Rosemary O'Connor
Journal:  J Biol Chem       Date:  2009-10-29       Impact factor: 5.157

Review 5.  Cytoplasmic vacuolization in cell death and survival.

Authors:  Andrey V Shubin; Ilya V Demidyuk; Alexey A Komissarov; Lola M Rafieva; Sergey V Kostrov
Journal:  Oncotarget       Date:  2016-08-23

6.  ATP6L promotes metastasis of colorectal cancer by inducing epithelial-mesenchymal transition.

Authors:  Jingyi Wang; Dandan Chen; Wangzhao Song; Zhiyong Liu; Wenjuan Ma; Xiaofeng Li; Chao Zhang; Xin Wang; Yalei Wang; Ye Yang; Wenfeng Cao; Lisha Qi
Journal:  Cancer Sci       Date:  2020-01-06       Impact factor: 6.716

7.  A novel brain-enriched E3 ubiquitin ligase RNF182 is up regulated in the brains of Alzheimer's patients and targets ATP6V0C for degradation.

Authors:  Qing Yan Liu; Joy X Lei; Marianna Sikorska; Rugao Liu
Journal:  Mol Neurodegener       Date:  2008-02-25       Impact factor: 14.195

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.